A pharmacoinformatic approach for studying Atractylodes Lancea DC’s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells

These findings demonstrate that ALD exerts potent anticancer effects against metastatic prostate cancer cells through ROS-mediated apoptosis and mitochondrial dysfunction, while exhibiting minimal cytotoxicity toward normal prostate cells. The presence of ac-tive compounds such as Atractylenolide II and III suggests a synergistic interaction that enhances AR inhibition and promotes apoptosis. ALD's ability to engage multiple path-ways highlights its therapeutic potential as a selective and multifaceted treatment for ag-gressive prostate cancer.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-02-05
DOI
https://doi.org/10.3389/fonc.2025.1471110
Citations
4
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
9.53

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A pharmacoinformatic approach for studying Atractylodes Lancea DC’s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells

Jinwon Choi, Kazi Rejvee Ahmed, Abdel Halim Harrath, Hwa‐Seung Yoo et al.
4 citations
Frontiers in Oncology
Traditional Chinese Medicine Analysis
9.53
article

A pharmacoinformatic approach for studying Atractylodes Lancea DC’s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells

Jinwon Choi, Kazi Rejvee Ahmed, Abdel Halim Harrath, Hwa‐Seung Yoo, Md. Maharub Hossain Fahim, Chi‐Hoon Ahn, Mohammed Dalli, K W Kim, Moon Nyeo Park, Rony Abdi Syahputra, Md. Ataur Rahman, Min Ji Choi, Bonglee Kim, Seungjoon Moon, M M Rahman, Sang‐Won Shin, Ji Soo Myong
article en
4 citations

Abstract

These findings demonstrate that ALD exerts potent anticancer effects against metastatic prostate cancer cells through ROS-mediated apoptosis and mitochondrial dysfunction, while exhibiting minimal cytotoxicity toward normal prostate cells. The presence of ac-tive compounds such as Atractylenolide II and III suggests a synergistic interaction that enhances AR inhibition and promotes apoptosis. ALD's ability to engage multiple path-ways highlights its therapeutic potential as a selective and multifaceted treatment for ag-gressive prostate cancer.

Frontiers in OncologyVol. 15
Daejeon University (KR), Wayne State University (US), Universitas Sumatera Utara (ID), King Saud University (SA), Kyung Hee University (KR), The Barbara Ann Karmanos Cancer Institute (US), Instituts Supérieurs des Professions Infirmières et Techniques de Santé (MA), Mohamed I University (MA), Pusan National University (KR)
National Research Foundation, King Saud University, Kyung Hee University, Korea Health Industry Development Institute, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Openalex Percentile: Top 3%
Traditional Chinese Medicine Analysis
9.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.